Home » Uncategorized » Page 2

Uncategorized

Featured posts

What if Marijuana Becomes a Schedule III Drug?

By Jonathan Baktari, MD, US Drug Test Centers With evolving legislation, the legalization of certain drugs continues to change. There have been a lot of question marks around THC, the psychoactive substance in marijuana. Over the years, we’ve watched as the...

Are you coming to NDASA’s 2025 Conference? Share your excitement

Let your professional contacts and industry colleagues know that you will be attending, sponsoring, training, speaking or exhibiting at NDASA's 2025 Conference & Tradeshow in Jacksonville this April by posting on social media. Attendees, exhibitors, sponsors,...

The state of drug testing across the nation

By Jonathan Baktari, MD, CEO of US Drug Test Centers The laws surrounding drug use and employment drug testing are rapidly changing, and many individuals and companies are having a hard time keeping up. The change, though, is needed: With marijuana use for both...

Podcast: Member's Memo

Updates on relevant industry news, compliance issues, regulatory changes and upcoming events.

All posts

From the Executive Director’s desk

Our "WHY" The heart and soul of NDASA has always been: taking the time to remember WHY we do what we do every day and inspiring our members to do the same. That may look different for you than it does for me or for our industry colleagues.  For many of our...

Hair testing: Proposed rule for Mandatory Guidelines for Federal Drug Testing Programs

The U.S. Department of Health and Human Services is proposing to establish scientific and technical guidelines for the inclusion of hair specimens in the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Guidelines). We encourage you to review the...